Structural investigation of deleterious non-synonymous SNPs of EGFR gene

Interdisciplinary Sciences – Computational Life Sciences

Volumn 5, Issue 1, 2013, Pages 60-68

  Raghav, Dhwani ^a,b   Sharma, Vinay ^b   Agarwal, Subhash Mohan ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b BANASTHALI UNIVERSITY   (India)

Author keywords

cancer; docking; Epidermal Growth Factor Receptor; GOLD; kinase; molecular dynamics simulation; mutations; SNP

Indexed keywords

EID: 84883293448     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-013-0149-x     Document Type: Article

References (26)

1. Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., Sunyaev, S. R. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249.
2. Avizienyte, E., Ward, R. A., Garner, A. P. 2008. Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations. Biochem J 415, 197-206.
3. Balak, M. N., Gong, Y., Riely, G. J., Somwar, R., Li, A. R., Zakowski, M. F., Chiang, A., Yang, G., Ouerfelli, O., Kris, M. G., Ladanyi, M., Miller, V. A., Pao, W. 2006. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clin Cancer Res 12, 6494-6501.
4. Capriotti, E., Fariselli, P., Casadio, R. 2005. IMutant2. 0: Predicting stability changes upon mutation from the protein sequence or structure. Nucl Acid Res 33, W306-310.
5. De Alencar, S. A., Lopes, J. C. 2010. A comprehensive in silico analysis of the functional and structural impact of SNPs in the IGF1R gene. J Biomed Biotechnol 2010, Article ID: 715139.
6. Guex, N., Diemand, A., Pettsch, M. C. 1999. Protein modelling for all. Trends Biochem Sci 24, 364-367.
7. Hall, T. A. 1999. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41, 95-98.
8. Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E. 2008. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4, 435-447.
9. Huang, L. T., Gromiha, M. M., Ho, S. Y. 2007. iPTREESTAB: Interpretable decision tree based method for predicting protein stability changes upon mutations. Bioinformatics 23, 1292-1293.
10. Humphrey, W., Dalke, A., Schulten, K. 1996. VMD: Visual molecular dynamics. J Mol Graphics 14, 33-38.
11. Jones, G., Willett, P., Glen, R. C., Leach, A. R., Taylor, R. 1997. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267, 727-748.
12. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P., Ward, C. W., Burgess, A. W. 2003. Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp Cell Res 284, 31-53.
13. Kumar, A., Petri, E. T., Halmos, B., Boggon, T. J. 2008. Structure and clinical relevance of the epidermal growth factor receptor in human cancer. J Clin Oncol 26, 1742-1751.
14. Linardou, H., Dahabreh, I. J., Bafaloukos, D., Kosmidis, P., Murray, S. 2009. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol 6, 352-366.
15. Matthews, D. J., Gerritsen, M. E. 2010. Targeting Protein Kinases for Cancer Therapy, 1st Ed. John Wiley & Sons, Inc., USA.
16. Murray, S., Dahabreh, I. J., Linardou, H., Manoloukos, M., Bafaloukos, D., Kosmidis, P. 2008. Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: An analytical database. J Thorac Oncol 3, 832-839.
17. Ng, P. C., Henikoff, S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucl Acid Res 31, 3812-3814.
18. Parthiban, V., Gromiha, M. M., Schomburg D. 2006. CUPSAT: Prediction of protein stability upon point mutations. Nucl Acid Res 34, W239-242.
19. Rajasekaran, R., Sethumadhavan, R. 2010. In silico identification of significant detrimental missense mutations of EGFR and their effect with 4-anilinoquinazoline-based drugs. Appl Biochem Biotechnol 160, 1723-1733.
20. Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., Sirotkin, K. 2001. dbSNP: The NCBI database of genetic variation. Nucl Acid Res 29, 308-311.
21. Snow, J. B., Wackym, A. P. 2009. Ballenger's Otorhinolaryngology: Head and Neck Surgery, 17th Ed. Peoples Medical Publishing House, Shelton, USA.
22. Stein, R. A., Staros V. J. 2006. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis. BMC Evol Bio 6, 79.
23. Wallace, A. C., Laskowski, R. A., Thornton, J. M. 1995. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8, 127-134.
24. West, C. M., Joseph, L., Bhana, S. 2008. Epidermal growth factor receptor-targeted therapy. Br J Radiol 81, S36-44.
25. Yuan, H. Y., Chiou, J. J., Tseng, W. H., Liu, C. H., Liu, C. K., Lin, Y. J., Wang, H. H., Yao, A., Chen, Y. T., Hsu, C. N. 2006. FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization. Nucl Acid Res 34, 635-641.
26. Zhang, X., Gureasko, J., Shen, K., Cole, P. A., Kuriyan, J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-1149.